首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors
【24h】

Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors

机译:设计,合成和分子模拟芦荟大黄素衍生物作为有效的黄嘌呤氧化酶抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

A series of aloe-emodin derivatives were synthesized and evaluated as xanthine oxidase inhibitors. Among them, four aloe-emodin derivatives showed significant inhibitory activities against xanthine oxidase. The compound 4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carbaldehyde (A1) possessed the best xanthine oxidase inhibitory activity with IC50 of 2.79 μM. Lineweaver-Burk plot analysis revealed that A1 acted as a mixed-type inhibitor for xanthine oxidase. The docking study revealed that the molecule A1 had strong interactions with the active site of xanthine oxidase and this result was in agreement with kinetic study. Consequently, compound A1 is a new-type candidate for further development for the treatment of gout.
机译:合成了一系列芦荟大黄素衍生物,并被评价为黄嘌呤氧化酶抑制剂。其中,四种芦荟大黄素衍生物对黄嘌呤氧化酶具有明显的抑制活性。化合物4,5-二羟基-9,10-二氧代-9,10-二氢蒽-2-甲醛(A1)具有最佳的黄嘌呤氧化酶抑制活性,IC50为2.79μM。 Lineweaver-Burk图分析表明,A1是黄嘌呤氧化酶的混合型抑制剂。对接研究表明,分子A1与黄嘌呤氧化酶的活性位点具有很强的相互作用,这一结果与动力学研究相符。因此,化合物A1是用于治疗痛风的进一步开发的新型候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号